Entering the first week of March, the market continued its previous trend, and the entire environment was still in a state of recovery. The overall oversupply continues, but downstream construction has started one after another and entered the state. The market trading atmosphere has shown signs of easing. The overall transaction volume is acceptable. The pessimism has gradually reversed. Gentamicin sulfate has experienced slight fluctuations and slightly increased. The trading of amoxicillin, amoxicillin-clavulanate potassium, neomycin sulfate, oxytetracycline, tilmicosin, lincomycin sulfate, sulfamethoxine sodium, metamizole, taurine and other products has rebounded , the decline of other products slowed down, and basically maintained stable operation, with little price fluctuation.

Comparison of product prices in the same period in March

March this year was relatively inferior to previous years. It can be seen from the bar chart that the market for veterinary drug raw materials has been on a downward trend year by year in recent years. Bulk products have experienced larger declines, and niche products have also been reduced accordingly.

The National Two Sessions were held recently, and animal husbandry Industry representatives have made suggestions. Liu Yonghao, a member of the National Committee of the Chinese People's Political Consultative Conference and chairman of New Hope Group, said that it is expected that pork prices will be very likely to return above the cost line in the second half of this year, and the breeding industry is likely to recover, driving the "pig-based" veterinary drug raw materials Increased demand in the pharmaceutical market. Qin Yinglin, deputy to the National People's Congress and chairman of Muyuan Co., Ltd., suggested using technological innovation to drive high-quality development of the pig industry. Zhang Weiyuan, a member of the National Committee of the Chinese People's Political Consultative Conference and chairman of Huisheng Biotech, suggested strengthening the allocation of review resources and increasing support for innovative veterinary drugs. Representative members actively strive for favorable policies for the animal husbandry industry, release positive signals, and warm up the veterinary drug raw material market this year.